EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evidence Supporting Autotaxin as a Potential New Drug Treatment Target in Patients With Advanced Diabetic Retinopathy

Harumasa Yokota, Hiroki Hayashi, Hironori Nakagami, Akifumi Kushiyama, Junya Hanaguri, Megumi Honjo, Makoto Aihara, Makoto Kurano, Koji Igarashi, Sakura Kushiyam, Satoru Yamagami, Taiji Nagaoka

Investigative Ophthalmology & Visual Science · 16.12.2025 · 66 (15) · 49

DOI: 10.1167/iovs.66.15.49 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 16.12.2025. Verfasst von Harumasa Yokota und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Japan. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Phosphoric Diester Hydrolases, Vitreous Body. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyPhosphoric Diester HydrolasesVitreous BodyAnimalsMiceHumansMaleFemaleElectroretinographyMiddle AgedDisease Models, AnimalEnzyme-Linked Immunosorbent AssayMice, Inbred C57BLDiabetes Mellitus, Type 2AgedDisease ProgressionAdultLaser-Doppler FlowmetryRetinaRegional Blood FlowLysophospholipase D

Substanzen

Phosphoric Diester HydrolasesLysophospholipase D

Autor:innen und Institutionen

  • Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Japan.
  • Division of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine, Tokyo, Japan.
  • Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Department of Pharmacotherapy, Meiji Pharmaceutical University, Tokyo, Japan.
  • Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Clinical Laboratory, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Zitieren

APA

Yokota, H., Hayashi, H., Nakagami, H., Kushiyama, A., Hanaguri, J., Honjo, M., Aihara, M., Kurano, M., Igarashi, K., Kushiyam, S., Yamagami, S., & Nagaoka, T. (2025). Evidence Supporting Autotaxin as a Potential New Drug Treatment Target in Patients With Advanced Diabetic Retinopathy. Investigative Ophthalmology & Visual Science, 66(15), 49. https://doi.org/10.1167/iovs.66.15.49

Vancouver

Yokota H, Hayashi H, Nakagami H, Kushiyama A, Hanaguri J, Honjo M, et al. Evidence Supporting Autotaxin as a Potential New Drug Treatment Target in Patients With Advanced Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 2025;66(15):49. doi:10.1167/iovs.66.15.49

BibTeX
@article{Yokota2025,
  author = {Yokota, Harumasa and Hayashi, Hiroki and Nakagami, Hironori and Kushiyama, Akifumi and Hanaguri, Junya and Honjo, Megumi and Aihara, Makoto and Kurano, Makoto and Igarashi, Koji and Kushiyam, Sakura and Yamagami, Satoru and Nagaoka, Taiji},
  title = {Evidence Supporting Autotaxin as a Potential New Drug Treatment Target in Patients With Advanced Diabetic Retinopathy},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  volume = {66},
  number = {15},
  pages = {49},
  doi = {10.1167/iovs.66.15.49}
}
Kostenlos starten →